{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:53:25Z","timestamp":1740135205835,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012353","name":"German Cancer Consortium","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["TransLUMINAL-B"],"award-info":[{"award-number":["TransLUMINAL-B"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12859-018-2159-5","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T08:10:25Z","timestamp":1524557425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1959-2240","authenticated-orcid":false,"given":"Jan","family":"Budczies","sequence":"first","affiliation":[]},{"given":"Nicole","family":"Pfarr","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Romanovsky","sequence":"additional","affiliation":[]},{"given":"Volker","family":"Endris","sequence":"additional","affiliation":[]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"issue":"16","key":"2159_CR1","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353(16):1673\u201384.","journal-title":"N Engl J Med"},{"issue":"10","key":"2159_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/2159-8290.CD-12-0108","volume":"2","author":"K Takezawa","year":"2012","unstructured":"Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, et al. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Discov. 2012;2(10):922\u201333.","journal-title":"Cancer Discov"},{"issue":"52","key":"2159_CR3","doi-asserted-by":"publisher","first-page":"20932","DOI":"10.1073\/pnas.0710370104","volume":"104","author":"J Bean","year":"2007","unstructured":"Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A. 2007;104(52):20932\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2159_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","volume":"22","author":"T Helsten","year":"2016","unstructured":"Helsten T, Elkin S, Arthur E, Tomson BN, Carter J, Kurzrock R. The FGFR landscape in Cancer: analysis of 4,853 tumors by next-generation sequencing. Clin Cancer Res. 2016;22(1):259\u201367.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2159_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ijc.2910640511","volume":"64","author":"T Nakayama","year":"1995","unstructured":"Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer. 1995;64(5):342\u20136.","journal-title":"Int J Cancer"},{"issue":"20","key":"2159_CR6","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1158\/1078-0432.CCR-17-1480","volume":"23","author":"A Forschner","year":"2017","unstructured":"Forschner A, Niessner H, Moller Y, Horak P, Frohlich M, Warsow G, Stenzinger A, Frohling S, Glimm H, Klumpp B, et al. Genomics of immunotherapy-associated Hyperprogressors-letter. Clin Cancer Res. 2017;23(20):6374\u20135.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2159_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmoldx.2013.06.002","volume":"15","author":"V Endris","year":"2013","unstructured":"Endris V, Penzel R, Warth A, Muckenhuber A, Schirmacher P, Stenzinger A, Weichert W. Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing. J Mol Diagn. 2013;15(6):765\u201375.","journal-title":"J Mol Diagn"},{"issue":"11","key":"2159_CR8","doi-asserted-by":"publisher","first-page":"13236","DOI":"10.18632\/oncotarget.7451","volume":"7","author":"J Budczies","year":"2016","unstructured":"Budczies J, Pfarr N, Stenzinger A, Treue D, Endris V, Ismaeel F, Bangemann N, Blohmer JU, Dietel M, Loibl S, et al. Ioncopy: a novel method for calling copy number alterations in amplicon sequencing data including significance assessment. Oncotarget. 2016;7(11):13236\u201347.","journal-title":"Oncotarget"},{"issue":"4","key":"2159_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/gcc.22431","volume":"56","author":"N Pfarr","year":"2017","unstructured":"Pfarr N, Penzel R, Endris V, Lier C, Flechtenmacher C, Volckmar AL, Kirchner M, Budczies J, Leichsenring J, Herpel E, et al. Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance. Genes Chromosomes Cancer. 2017;56(4):255\u201365.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2159_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jmoldx.2016.09.010","volume":"19","author":"DS Ross","year":"2017","unstructured":"Ross DS, Zehir A, Cheng DT, Benayed R, Nafa K, Hechtman JF, Janjigian YY, Weigelt B, Razavi P, Hyman DM, et al. Next-generation assessment of human epidermal growth factor receptor 2 (ERBB2) amplification status: clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay. J Mol Diagn. 2017;19(2):244\u201354.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2159_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jmoldx.2014.09.004","volume":"17","author":"M Hoogstraat","year":"2015","unstructured":"Hoogstraat M, Hinrichs JW, Besselink NJ, Radersma-van Loon JH, de Voijs CM, Peeters T, Nijman IJ, de Weger RA, Voest EE, Willems SM, et al. Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology. J Mol Diagn. 2015;17(1):10\u20138.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2159_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jmoldx.2013.08.004","volume":"16","author":"CC Pritchard","year":"2014","unstructured":"Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A, et al. Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. J Mol Diagn. 2014;16(1):56\u201367.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2159_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","volume":"17","author":"C Grasso","year":"2015","unstructured":"Grasso C, Butler T, Rhodes K, Quist M, Neff TL, Moore S, Tomlins SA, Reinig E, Beadling C, Andersen M, et al. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. J Mol Diagn. 2015;17(1):53\u201363.","journal-title":"J Mol Diagn"},{"issue":"11","key":"2159_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/gcc.22378","volume":"55","author":"N Pfarr","year":"2016","unstructured":"Pfarr N, Penzel R, Klauschen F, Heim D, Brandt R, Kazdal D, Jesinghaus M, Herpel E, Schirmacher P, Warth A, et al. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-a survey across 822 routine diagnostic cases. Genes Chromosomes Cancer. 2016;55(11):821\u201333.","journal-title":"Genes Chromosomes Cancer"},{"key":"2159_CR15","unstructured":"Oliveira C, Wolf T. CNVPanelizer: reliable CNV detection in targeted sequencing applications. R package version 1.8.0. 2016; \n                    https:\/\/bioconductor.org\/packages\/CNVPanelizer\n                    \n                  ."},{"key":"2159_CR16","unstructured":"Budczies J, Romanovsky E. Ioncopy: calling copy number alterations in amplicon sequencing data. R package version 2.0.1. 2017; \n                    https:\/\/cran.r-project.org\/package=ioncopy"},{"key":"2159_CR17","volume-title":"Statistical methods for research workers","author":"RA Fisher","year":"1925","unstructured":"Fisher RA. Statistical methods for research workers. Edinburgh: Statistical Methods for Research Workers; 1925."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2159-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T19:03:20Z","timestamp":1556046200000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2159-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2159"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2159-5","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2018,4,24]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Generation and analysis of the data presented as use case was approved by the ethics board of the Charit\u00e9 Hospital (Reference number EA1\/139\/05 Amendment 2008).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}